Phase II trial of nab-paclitaxel in patients with relapsed or refractory multiple myeloma

Am J Hematol. 2016 Dec;91(12):E504-E505. doi: 10.1002/ajh.24548. Epub 2016 Oct 11.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Albumins / administration & dosage
  • Albumins / pharmacology
  • Albumins / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology
  • Paclitaxel / administration & dosage
  • Paclitaxel / pharmacology
  • Paclitaxel / therapeutic use*
  • Recurrence

Substances

  • 130-nm albumin-bound paclitaxel
  • Albumins
  • Paclitaxel